Clinical Trial Update: GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial studied the effects of glucose-dependent insulinotropic peptide (GIP) during insulin-induced hypoglycemia in patients with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GIP (glucose-dependent insulinotropic polypeptide)

Snippet

Sponsor: Mikkel Christensen | Conditions: Type 2 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED